Thymosin Alpha-1 10mg · Lyophilised Powder
Healing & Recovery

Thymosin Alpha-1

10mg · Lyophilised Powder

$120 AUD

Third-party tested — independent batch verification
99%+ purity — HPLC & mass spectrometry confirmed
Batch certificate accessible via QR code
Fast, discreet shipping Australia-wide

For laboratory research use only. Not for human consumption. Must be handled by qualified researchers in accordance with applicable regulations.

Product

Overview

Thymosin Alpha-1 (Ta1) is a naturally occurring 28-amino-acid peptide originally isolated from thymosin fraction 5 of bovine thymus. It is encoded by the PTMA gene and produced endogenously by thymic epithelial cells. The synthetic form has been studied extensively as an immune modulator across a range of research and clinical contexts.

Research

Scientific Overview

Thymosin Alpha-1 has been investigated in clinical and preclinical settings for its immunostimulatory properties. Research has examined its role in T-cell maturation, dendritic cell function, and the modulation of adaptive immune responses. It has been studied in the context of viral infections, sepsis models, immune deficiency states, and tumour immunology. Its capacity to restore impaired T-cell responses in aged or immunocompromised biological systems has been a persistent research focus.

Biology

Mechanism of Action

Thymosin Alpha-1 acts on Toll-like receptor 9 (TLR9) signalling pathways in dendritic cells, promoting their maturation and capacity to activate naive T lymphocytes. It promotes differentiation of T-helper cells toward a Th1 phenotype, enhancing cell-mediated immunity. Ta1 also upregulates MHC class I expression on tumour and virally infected cells, increasing their susceptibility to cytotoxic T-lymphocyte clearance. Additional mechanisms include induction of IFN-alpha/beta, IL-2, and IL-12 expression in lymphocytic cell populations.

Science

Areas of Research

Immune Biology T-Cell Research Antiviral Research Tumour Immunology Dendritic Cell Biology Immunomodulation
Verification

Third-Party Testing

Every batch of Thymosin Alpha-1 supplied by Pure Recovery Labs is independently analysed by a third-party laboratory prior to release. Purity is confirmed via HPLC and mass spectrometry to a minimum of 99%. A certificate of analysis is accessible via QR code on each product and through the Quality page.

View Certificates
Important

Research Use Only

Thymosin Alpha-1 is supplied exclusively for in vitro and preclinical laboratory research. It is not intended for, and must not be used in, humans or animals. It is not a medicinal product, therapeutic agent, supplement, cosmetic, or food substance. All handling must comply with applicable institutional and regulatory requirements. Pure Recovery Labs makes no claims regarding therapeutic efficacy or safety in any biological system.